- 2.9Impact Factor
- 5.2CiteScore
- 18 daysTime to First Decision
Advances in Immunohematology: From Pathophysiology to Tailored Treatments
This special issue belongs to the section “Immunology & Rheumatology“.
Special Issue Information
Dear Colleagues,
It is my pleasure to invite you and members of your research group to submit an article for a Special Issue entitled “Advances in Immunohematology: From Pathophysiology to Tailored Treatments”.
In recent years, the field of immuno-hematology has rapidly expanded, with improved characterization of the pathogenic mechanisms linking inborn errors of immunity and hematological diseases (autoimmune cytopenia, lymphoproliferation, malignancies, and hemophagocytic lymphohistiocytosis). Moreover, there has been an increasing use of immunological therapeutic strategies (i.e., monoclonal antibodies) in both benign and hematological diseases.
With this Special Issue, we aim to provide an overview of the most relevant innovations in immuno-hematology, with a focus on clinical and therapeutic perspectives. We welcome the submission of original research and review papers addressing, but not limited to, the following topics:
- Inborn errors of immunity with hematological involvement;
- Cellular therapies for hematological diseases;
- Hematopoietic stem cell transplantation for inborn errors of immunity and hematological diseases;
- Precision medicine in immuno-hematology;
- Immunization strategies in patients with immunohematological diseases.
Dr. Giorgio Costagliola
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune cytopenia
- hemophagocytic lymphohistiocytosis
- inborn errors of immunity
- lymphoproliferative diseases
- malignancy
- monoclonal antibodies
- secondary immunodeficiency
- vaccination
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

